Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma
-
Published:2020-08
Issue:
Volume:135
Page:203-210
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
McGregor Bradley A.ORCID,
Lalani Aly-Khan A.,
Xie Wanling,
Steinharter John A.,
E. Bakouny ZiadORCID,
Martini Dylan J.,
Fleischer Justin H.,
Abou-Alaiwi Sarah,
Nassar AminORCID,
Nuzzo Pier V.,
Kaymakcalan Marina D.,
Braun David A.,
Wei Xiao X.,
Harshman Lauren C.,
Bilen Mehmet A.,
Choueiri Toni K.
Funder
Bristol Myers Squibb
Calithera
Exelixis and
Seattle Genetics
AbbVie
Novartis
Roche and
Ipsen
Bayer
Sotio
Bristol-Myers Squib
Merck
Takeda
Dendreon/Valient
Jannsen
Genentech
Pfizer
Xencor
Incyte
Nektar
AstraZeneca
Tricon Pharmaceuticals
Peleton
Subject
Cancer Research,Oncology
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献